Recurrent VTE occurred in @ of @ patients treated with tinzaparin and @ of @ patients treated with warfarin ( @-month cumulative incidence , @ % for tinzaparin vs @ % for warfarin ; hazard ratio -LSB- HR -RSB- , @ -LSB- @ % CI , @-@ @ -RSB- ; P = @ ) .